These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19212335)

  • 1. The CLLU1 expression level is a stable and inherent feature of the chronic lymphocytic leukemia clone.
    Buhl AM; Novotny GW; Josefsson P; Nielsen JE; Pedersen LB; Geisler C; Rassenti LZ; Kipps TJ; Jurlander J; Leffers H
    Leukemia; 2009 Jun; 23(6):1182-6. PubMed ID: 19212335
    [No Abstract]   [Full Text] [Related]  

  • 2. The Impact and Prognostic Significance of Chronic Lymphocytic Leukemia Upregulated 1 (CLLU1) Gene Expression in Patients with Chronic Lymphocytic Leukemia: A Single Center Experience.
    Sevinc M; Karabulut A; Eskazan AE; Catal Tatonyan S; Ozbek U; Soysal T
    Lab Med; 2020 May; 51(3):259-264. PubMed ID: 31589746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CLLU1 expression levels predict time to initiation of therapy and overall survival in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Geisler CH; Pedersen LB; Andersen MK; Josefsson P; Petersen JH; Leffers H
    Eur J Haematol; 2006 Jun; 76(6):455-64. PubMed ID: 16529606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of CLLU1 in patients with chronic lymphocytic leukemia and its prognostic significance].
    Chen LJ; Zheng WJ; Wu YJ; Li L; Qian SX; Xu W; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):737-40. PubMed ID: 18457263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CLLU1 expression distinguishes chronic lymphocytic leukemia from other mature B-cell neoplasms.
    Oppliger Leibundgut E; Rogenmoser-Dissler D; de Beer D; Porret NA; Zibellini S; Dürig J; Röth A; Klingbiel D; Baerlocher GM
    Leuk Res; 2012 Sep; 36(9):1204-7. PubMed ID: 22738889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLLU1 as an emerging biomarker in chronic lymphoid leukemia.
    Rong C; Liang C; Shen J; Zhang Y; Wang Q; Yang F; Chen Y; Luo Y; Gu M; Gao P; Xia Y; Duan S
    Hum Cell; 2024 May; 37(3):625-632. PubMed ID: 38507118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fluorescent In Situ Hybridization Aberrations and CLLU1 Expression on the Prognosis of Chronic Lymphocytic Leukemia: Presentation of 156 Patients from Turkey.
    Abur Ü; Oğur G; Akar ÖS; Altundağ E; Aymelek HS; Özatlı D; Turgut M
    Turk J Haematol; 2018 Mar; 35(1):61-65. PubMed ID: 29129824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia.
    Josefsson P; Geisler CH; Leffers H; Petersen JH; Andersen MK; Jurlander J; Buhl AM
    Blood; 2007 Jun; 109(11):4973-9. PubMed ID: 17284524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a gene on chromosome 12q22 uniquely overexpressed in chronic lymphocytic leukemia.
    Buhl AM; Jurlander J; Jørgensen FS; Ottesen AM; Cowland JB; Gjerdrum LM; Hansen BV; Leffers H
    Blood; 2006 Apr; 107(7):2904-11. PubMed ID: 16339396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic evaluation of CLLU1 expression levels in 50 Chinese patients with chronic lymphocytic leukemia.
    Chen L; Li J; Zheng W; Zhang Y; Wu Y; Li L; Qian S; Xu W
    Leuk Lymphoma; 2007 Sep; 48(9):1785-92. PubMed ID: 17786715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CLLU1 expression: the latest risk predictor in chronic lymphocytic leukemia.
    Rosenwald A
    Leuk Lymphoma; 2007 Sep; 48(9):1665-6. PubMed ID: 17786698
    [No Abstract]   [Full Text] [Related]  

  • 12. MicroRNA-155 regulates casein kinase 1 gamma 2: a potential pathogenetic role in chronic lymphocytic leukemia.
    Zhang T; Davidson-Moncada JK; Mukherjee P; Furman RR; Bhavsar E; Chen Z; Hakimpour P; Papavasiliou N; Tam W
    Blood Cancer J; 2017 Sep; 7(9):e606. PubMed ID: 28885613
    [No Abstract]   [Full Text] [Related]  

  • 13. Transformation of chronic lymphocytic leukemia into B-cell acute lymphoblastic leukemia.
    Yun S; Zhang L; Patel MR; Knepper TC; Chavez JC; Pinilla-Ibarz J
    Blood; 2018 Mar; 131(11):1258-1261. PubMed ID: 29437555
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of microRNAs in chronic lymphocytic leukemia (Review).
    Zhou XX; Wang X
    Mol Med Rep; 2013 Sep; 8(3):719-25. PubMed ID: 23900739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement.
    Maffei R; Fiorcari S; Martinelli S; Guarnotta C; Benatti S; Belmonte B; Potenza L; Luppi M; Marasca R
    Hematol Oncol; 2018 Feb; 36(1):372-375. PubMed ID: 28580615
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunophenotypic and genotypic characterization of B-cell chronic lymphocytic leukemia patients from northern Italy.
    Gandini D; Lanza F; Latorraca A; Levato F; Del Senno L; Castoldi G
    Haematologica; 1993; 78(1):18-24. PubMed ID: 8491418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-kappa B/Rel-regulated inhibitors of apoptosis.
    Munzert G; Kirchner D; Stobbe H; Bergmann L; Schmid RM; Döhner H; Heimpel H
    Blood; 2002 Nov; 100(10):3749-56. PubMed ID: 12411322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathogenesis of B-cell chronic lymphocytic leukemia: analysis of 13q14 chromosomal deletions.
    Migliazza A; Cayanis E; Bosch-Albareda F; Komatsu H; Martinotti S; Toniato E; Kalachikov S; Bonaldo MF; Jelene P; Ye X; Rzhetsky A; Qu X; Chien M; Inghirami G; Gaidano G; Vitolo U; Saglio G; Resegotti L; Zhang P; Soares MB; Russo J; Fischer SG; Edelman IS; Efstratiadis A; Dalla-Favera R
    Curr Top Microbiol Immunol; 2000; 252():275-84. PubMed ID: 11125485
    [No Abstract]   [Full Text] [Related]  

  • 19. Proliferative activity in non-Hodgkin's lymphomas and chronic lymphocytic leukemias as determined on cytological samples by Ki 67 monoclonal antibody.
    Musto P; Melillo L; Lombardi G; Aieta M; Di Renzo N; Carotenuto M
    Haematologica; 1990; 75(6):583-4. PubMed ID: 2098303
    [No Abstract]   [Full Text] [Related]  

  • 20. Intercellular adhesion molecules (ICAMs) 2 and 3 are frequently expressed in B cell chronic lymphocytic leukemia.
    Molica S; Dattilo A; Mannella A; Levato D
    Leukemia; 1996 May; 10(5):907-8. PubMed ID: 8656688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.